多囊卵巢综合征与睡眠障碍的相关性研究

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (704 KB) HTML (0 KB)
输出: BibTeX | EndNote (RIS)

摘要多囊卵巢综合征(PCOS)是困扰女性最常见的生殖内分泌紊乱性疾病。睡眠障碍,包括阻塞性睡眠呼吸暂停和失眠。PCOS患者睡眠障碍常见。PCOS的病理生理学涉及胰岛素抵抗、皮质醇及褪黑素的变化,心理和行为方式也可能发挥作用,如焦虑、抑郁,吸烟或饮酒、及缺乏体力活动等。肥胖和胰岛素抵抗已成为PCOS和睡眠障碍的关键环节,且PCOS和睡眠障碍都与长期心血管代谢状况恶化和2型糖尿病风险增加有关。将睡眠障碍的诊断和管理作为跨学科保健的一部分,PCOS患者的生活质量和长期健康状况都会从中受益。本文就PCOS和睡眠障碍的相关性进行综述。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	徐荣
	邵海琳

关键词 ：多囊卵巢综合征, 睡眠障碍, 胰岛素抵抗

收稿日期: 2019-09-23

通讯作者: 邵海琳(54944219@qq.com)

引用本文:

徐荣, 邵海琳. 多囊卵巢综合征与睡眠障碍的相关性研究[J]. 中国生育健康杂志, 2021, 32(5): 496-498.

链接本文:

http://cjrh.bjmu.edu.cn/CN/ 或 http://cjrh.bjmu.edu.cn/CN/Y2021/V32/I5/496

1 Lizneva D,Suturina L,Walker W,et al.Criteria,prevalence,and phenotypes of polycystic ovary syndrome.Fertil Steril,2016,106:6-15.
2 El Hayek S,Bitar L,Hamdar LH,et al.Polycystic ovarian syndrome:an updated overview.Front Physiol,2016,7:124.
3 March WA,Moore VM,Willson KJ,et al.The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.Hum Reprod,2010,25:544-551.
4 中华医学会神经病学分会,中华医学会神经病学分会睡眠障碍学组.中国成人失眠诊断与治疗指南(2017版).中华神经科杂志,2018,51:324-335.
5 Epstein LJ,Kristo D,Strollo PJ Jr,et al.Adult obstructive sleep apnea task force of the American Academy of Sleep Medicine.Clinical guideline for the evaluation,management and longterm care of obstructive sleep apnea in adults.J Clin Sleep Med,2009,5:263-276.
6 Hillman DR,Lack LC.Public health implications of sleep loss:the community burden.Med J Aust,2013,199:S7-S10.
7 Renae F,Vivienne M,Emer V R,et al.Sleep disturbances in women with polycystic ovary syndrome:prevalence,pathophysiology,impact and management strategies.Nat Sci Sleep,2018,10:45-64.
8 Chatterjee B,Mittal P,Adhikari T.Obesity may be the common pathway for sleep-disordered breathing in women with polycystic ovary syndrome.Sleep Med,2016,23:32-39.
9 Teede HJ,Misso ML,Costello MF,et al.International PCOS Network.Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.Hum Reprod,2018,33:1602-1618.
10 Zwirska-Korczala K,Sodowski K,Konturek SJ,et al.Postprandial response of ghrelin andPYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.J Physiol Pharmacol,2008,59 Suppl 2:161-178.
11 Schwartz AR,Patil SP,Laffan AM,et al.Obesity and obstructive sleep apnea:pathogenic mechanisms and therapeutic approaches.Proc Am Thorac Soc,2008,5:185-192.
12 Mokhlesi B,Scoccia B,Mazzone T,Sam S.Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women.Fertil Steril,2012,97:786-791.
13 Diamanti-Kandarakis E,Papalou O,Kandaraki EA,et al.Mecha-nisms in endocrinology:nutrition as a mediator of oxidative stress in metabolic and reproductive disorders in women.Eur J Endocrinol,2017,176:R79-R99.
14 Vgontzas AN,Legro RS,Bixler EO,et al.Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness:role of insulin resistance.J Clin Endocrinol Metab,2001,86:517-520.
15 Rao MN,Neylan TC,Grunfeld C,et al.Subchronic sleep restriction causes tissue-specificinsulin resistance.J Clin Endocrinol Metab,2015,100:1664-1671.
16 李洪梅,韩旸,王凯亮.CPAP对2型糖尿病合并OSAHS患者的临床疗效观察.世界睡眠医学杂志,2019,6:11-13.
17 Goodman NF,Cobin RH,Futterweit W,et al.American association of clinical endocrinologists,American college of endocrinology,and androgen excess and PCOS society disease state clinical review:guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part2. Endocr Pract,2015,21:1415-1426.
18 Tasali E,Van Cauter E,Ehrmann DA.Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome.J Clin Endocrinol Metab,2006,91:36-42.
19 Haus E,Smolensky M.Biological clocks and shift work:circadian dysregulation and potential long-term effects.Cancer Causes Control,2006,17:489-500.
20 American Academy of Sleep Medicine.International Classification of Sleep Disorders(3rd ed.).Darien,IL:American Academy of Sleep Medicine,2014.
21 Dedovic K,Ngiam J.The cortisol awakening response and major depression:examining the evidence.Neuropsychiatr Dis Treat,2015,11:1181-1189.
22 Garcia AN,Salloum IM.Polysomnographic sleep disturbances in nicotine,caffeine,alcohol,cocaine,opioid,and cannabis use:a focused review.Am J Addict,2015,24:590-598.
23 Zomers ML,Hulsegge G,van Oostrom SH,et al.Characterizing adult sleep behavior over 20 years-the population-based Doetinchem Cohort Study.Sleep,2017,40:zsx085.
24 Chen LJ,Steptoe A,Chen YH,et al.Physical activity,smoking,and the incidence of clinically diagnosed insomnia.Sleep Med,2017,30:189-194.
25 Mahalingaiah S,Diamanti—Kandarakis E.Targets to treat metabolic syndrome in polycystic ovary syndrome.Expert Opin Ther Targets,2015,19:1561-1574.
26 Gonzaga C,Bertolami A,Bertolami M,et al.Obstructive sleep apnea,hypertension and cardiovascular diseases.J Hum Hypertens,2015,29:705-712.
27 Doonan RJ,Scheffler P,Lalli M,et al.Increased arterial stiffness in obstructive sleep apnea:a systematic review.Hypertens Res,2011,34:23-32.
28 Chatterjee B,Suri J,Suri JC,et al.Impact of sleep-disordered breathing on metabolic dysfunctions in patients with polycystic ovary syndrome.Sleep Med,2014,15:1547-1553.
29 Lack L,Sweetman A.Diagnosis and treatment of insomnia comorbid with obstructive sleep apnea.Sleep Med Clin,2016,11:379-388.
30 Bajuk Studen K,Pfeifer M.Cardiometabolic risk in polycystic ovary syndrome.Endocr Connect,2018,7:R238-R251.
31 Irish LA,Kline CE,Gunn HE,et al.The role of sleep hygiene in promoting public health:a review of empirical evidence.Sleep Med Rev,2015,22:23-36.
32 Lin TY,Lin PY,Su TP,et al.Risk of developing obstructive sleep apnea among women with polycystic ovarian syndrome:a nationwide longitudinal follow-up study.Sleep Med,2017,36:165-169.
33 Suri J,Suri JC,Chatterjee B,et al.Obesity may be the common pathway for sleep-disordered breathing in women with polycystic ovary syndrome.Sleep Med,2016,23:32-39.